A method for detecting D-3-acetylmercapto-2-methylpropionyl chloride in captopril by gas chromatography-mass spectrometry
The detection of D-3-acetylthio-2-methylpropionyl chloride after esterification was solved by gas chromatography-mass spectrometry combination technology, which failed to effectively detect the impurity in captopril in the prior art, and achieved rapid Accurate testing improves the quality of drugs and the safety of medication.
Patent Information
- Application Number
- CN202010613631.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2020-06-30
- Publication Date
- 2024-11-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The prior art cannot effectively detect the genotoxic impurity D-3-acetylthio-2-methylpropionyl chloride in captopril, resulting in imperfect analysis technology for drug genotoxic impurities, affecting drug quality and drug safety.
Gas chromatography-mass spectrometry combined technology was used to detect the genotoxic impurity D-3-acetylthio-2-methylpropionyl chloride in captopril, and the analysis was carried out after esterification to ensure the accuracy and sensitivity of the detection.
The rapid and accurate detection of the genotoxic impurity D-3-acetylthio-2-methylpropionyl chloride in captopril was achieved, and the quality of the drug and the safety of clinical medication were improved.
Smart Images

Figure CN111721879B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of drug analysis, and in particular relates to a method for detecting genotoxic impurity D-3-acetylmercapto-2-methylpropionyl chloride in captopril. Background Art
[0002] Genotoxic impurities refer to substances that can directly or indirectly damage DNA, and can cause damage to human genetic material at very low concentrations, leading to gene mutations or carcinogenic tendencies, which seriously threaten human health during medication. In recent years, genotoxic impurities have gradually attracted widespread attention due to their significant safety risks. In order to avoid passive ingestion of genotoxic impurities and ensure drug quality and drug safety, it is of great significance to develop accurate identification and monitoring methods for drug genotoxic impurities. Regulatory agencies in various countries, such as EMEA, FDA, ICH and other agencies, have successively issued guidelines for genotoxic impurities, and put forward requirements for the control and evaluation of such impurities.
[0003] Captopril is the earliest discovered angiotensin converting enzyme inhibitor. It has good efficacy, does not produce postural hypotension, improves cardiac function, increases renal blood flow, and is one of the first choice drugs for the treatment of hypertension and congestive heart failure. Captopril may contain potential genotoxic impurities D-3-acetylmercapto-2-methylpropionyl chloride in the synthesis process, and there is no report on its determination method. Due to the special requirements of genotoxic impurity detection in terms of sensitivity, selectivity, stability of the analyte, matrix complexity, etc., its analysis method is different from the requirements of other impurity detection. At present, the analysis technology of drug genotoxic impurities is still very imperfect, resulting in incomplete judgment and mastery of genotoxic impurities by enterprises, high R&D costs, and the need for "supplementation" for drug registration and approval analysis, which affects the speed of R&D, product quality and international competitiveness. Therefore, it is extremely necessary to establish a method for accurate and rapid quantitative detection and analysis of the genotoxic impurity D-3-acetylmercapto-2-methylpropionyl chloride in the drug captopril. Summary of the invention
[0004] The technical problem to be solved by the present invention is to provide a method with high accuracy, strong specificity and good reproducibility, which can accurately detect the genotoxic impurity D-3-acetylmercapto-2-methylpropionyl chloride in captopril. The present invention esterifies the unstable impurity D-3-acetylmercapto-2-methylpropionyl chloride and then uses gas chromatography-mass spectrometry technology for detection. The analysis method has the advantages of fast analysis speed and high sensitivity, thereby ensuring the quality of the captopril raw material and improving the safety of clinical drug use.
[0005] The present invention is achieved through the following technical solutions:
[0006] A method for detecting genotoxic impurity D-3-acetylmercapto-2-methylpropionyl chloride in a captopril raw material drug, the method using gas chromatography-mass spectrometry for detection, comprising the following steps:
[0007] (1) Preparation of test solution: Accurately weigh the captopril sample, dissolve it in an alcohol solvent and make up to volume, shake well to make a 0.05-0.20 g / mL solution, filter it through a microporous membrane, and take the filtrate as the test solution. At the same time, make a blank solution.
[0008] (2) Preparation of reference solution: Accurately weigh D-3-acetylmercapto-2-methylpropionyl chloride reference standard, place in a 25 mL volumetric flask, dissolve with alcohol solvent and dilute to the mark, shake well, and use as reference solution a; Accurately measure 50 μL of reference solution a, place in a 2 mL injection vial, add 950 μL of alcohol solvent, shake well, and use as reference solution b; Accurately measure 50 μL of reference solution b, place in a 2 mL injection vial, add 950 μL of alcohol solvent, shake well, and use as reference solution c. Accurately measure 100 μL of reference solution c, place in a 2 mL injection vial, add 900 μL of alcohol solvent, shake well, and use as reference solution.
[0009] Furthermore, the concentration of the test solution is 0.10 g / mL.
[0010] Furthermore, the concentration of the reference solution is 0.20-0.65 μg / mL.
[0011] Furthermore, the dilution solvents used for the test sample and reference sample solutions are alcohol solvents such as methanol, ethanol and isopropanol.
[0012] (3) Accurately measure 1.0 μL of each of the blank solution, reference solution, and test solution, inject them into a gas chromatograph-mass spectrometer for testing, and record the chromatogram. The gas chromatograph-mass spectrometer detection method conditions are as follows:
[0013] Gas chromatography conditions: chromatographic column is HP-5, 30m×0.25mm×0.25μm, UI; the stationary phase is 5% phenyl-95% dimethylpolysiloxane, the carrier gas is helium; the injection port temperature is 200-240°C; MS detector; the flow rate is 1.4-1.6mL / min; the split ratio is 10:1; the injection volume is 1.0μL.
[0014] Mass spectrometry conditions: ion source (EI) voltage, ionization energy: 70 eV, ion source temperature: 230 °C, quadrupole temperature: 150 °C, transfer line temperature: 280 °C, scanning mode: selected ion scanning, quantitative ions: 144, qualitative ions: 144, 134, 116, 101.
[0015] Furthermore, the gas chromatography column temperature conditions are as follows: the initial column temperature is 60-75°C, maintained for 1 minute, then increased to 180°C at a rate of 20°C / min, then increased to 260°C at a rate of 40°C / min, and maintained at 260°C for 10 minutes.
[0016] (4) Calculation: Calculate the content of D-3-acetylmercapto-2-methylpropanoyl chloride in the test sample using the peak area according to the external standard method.
[0017] Beneficial effects:
[0018] The method for determining the genotoxic impurity D-3-acetylmercapto-2-methylpropionyl chloride in captopril provided by the invention is quick and simple to operate, has high sensitivity, good repeatability, accurate results, can be detected qualitatively or quantitatively, provides a good reference for controlling the residual D-3-acetylmercapto-2-methylpropionyl chloride in the production process of the raw material drug captopril, ensures the quality of the raw material drug of terbutaline sulfate, and thus improves the safety of clinical drug use. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] Figure 1 D-3-acetylmercapto-2-methylpropionyl chloride method validation detection limit determination spectrum;
[0020] Figure 2 D-3-acetylmercapto-2-methylpropionyl chloride method validation quantitative limit determination spectrum;
[0021] Figure 3 D-3-acetylmercapto-2-methylpropionyl chloride method validation specificity determination reference substance spectrum;
[0022] Figure 4 D-3-acetylmercapto-2-methylpropionyl chloride method validation specificity determination test sample spectrum;
[0023] Figure 5 D-3-acetylmercapto-2-methylpropionyl chloride method validation limit recovery determination reference substance spectrum;
[0024] Figure 6 D-3-acetylmercapto-2-methylpropionyl chloride method validation limit recovery determination solvent spectrum;
[0025] Figure 7 D-3-acetylmercapto-2-methylpropionyl chloride method validation limit recovery determination blank sample spectrum;
[0026] Figure 8 D-3-acetylmercapto-2-methylpropionyl chloride method validation limit recovery determination 100% spectrum;
[0027] Fig. 9 D-3-acetylmercapto-2-methylpropionyl chloride reference material spectrum after method validation;
[0028] Fig.10 D-3-acetylmercapto-2-methylpropionyl chloride solvent spectrum after method verification;
[0029] Fig.11 D-3-Acetylmercapto-2-methylpropanoyl chloride sample spectrum after method validation. DETAILED DESCRIPTION
[0030] The technical solution of the present invention is further described below in conjunction with specific embodiments, but the present invention is not limited thereto.
[0031] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit the exemplary embodiments according to the present application. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprise" and / or "include" are used in this specification, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.
[0032] 1. Chromatographic / mass spectrometry conditions and system suitability test
[0033] According to the gas chromatography method (Chinese Pharmacopoeia 2015 Edition Part IV General Rules 0521), an analytical column (HP-5, 30m×0.25mm×0.25μm, UI) with a stationary phase of 5% phenyl-95% dimethylpolysiloxane was used. The initial column temperature was 70°C, maintained for 1 minute, raised to 180°C at a rate of 20°C per minute, and then raised to 260°C at a rate of 40°C per minute, maintained for 10 minutes. The injection port temperature was 220°C, and the MS detector was helium as the carrier gas. The flow rate was 1.5mL per minute, the split ratio was 10:1, and the injection volume was 1.0μL.
[0034] Mass spectrometry conditions: ion source (EI) voltage, ionization energy: 70 eV, ion source temperature: 230 °C, quadrupole temperature: 150 °C, transfer line temperature: 280 °C, scanning mode: selected ion scanning, quantitative ions: 144, qualitative ions: 144, 134, 116, 101.
[0035] Determination method: Take 1.0g of Captopril sample, accurately weigh, dissolve with methanol and make up to the scale, shake well, pass through a microporous filter membrane (filter membrane pore size is 0.45μm), take the filtrate as the test solution, and do a blank test at the same time; take an appropriate amount of D-3-acetylmercapto-2-methylpropionyl chloride reference substance, accurately weigh, dissolve with methanol and quantitatively dilute to make a solution containing about 0.33μg per 1mL as the reference solution. Accurately measure 1.0μL of blank solution, reference solution, and test solution, inject into gas chromatography-mass spectrometry, and record the chromatogram. If there is a chromatographic peak with the same retention time as the main peak of the reference solution in the chromatogram of the test solution, and the mass-to-charge ratio of the corresponding qualitative ion is consistent with that of the reference solution, and the abundance ratio is in the range specified in Table 1 compared with the reference solution, the D-3-acetylmercapto-2-methylpropionyl chloride content shall not exceed 3.33μg / mL calculated by the external standard method based on the quantitative ion peak area.
[0036] Table 1 Maximum allowable deviation of relative ion abundance for qualitative confirmation
[0037] Relative ion abundance (%) >50 >20~50 >10~20 ≤10 Maximum allowable deviation (%) ±20 ±25 ±30 ±50
[0038] 2. Validation of D-3-acetylmercapto-2-methylpropionyl chloride analytical method
[0039] Instrument: Agilent 7890B-5977B gas chromatograph-mass spectrometer; chromatographic column: HP-5 (30m×0.25mm×0.25μm, UI); reagents: methanol (chromatographic grade), D-3-acetylmercapto-2-methylpropanoyl chloride (purity 99.4%), captopril (raw material, Zhejiang Huahai Pharmaceutical Co., Ltd.).
[0040] 1. Detection limit and quantification limit: The detection limit and quantification limit were determined by the signal-to-noise ratio method. The detection limit was determined by the corresponding concentration when the quantitative ion signal-to-noise ratio was 3:1, and the result was 0.080μg / mL, which was 2.402% of the limit. The quantification limit was determined by the corresponding concentration when the quantitative ion signal-to-noise ratio was 10:1, and the result was 0.266μg / mL, which was 7.99% of the limit.
[0041] 2. Specificity: Take 26.81 mg of D-3-acetylmercapto-2-methylpropionyl chloride, accurately weigh it, place it in a 25 mL volumetric flask, dissolve it with methanol and make it up to the mark, shake it well, and use it as reference solution a; accurately measure 50 μL of reference solution a, place it in a 2 mL injection vial, add 950 μL of methanol, shake it well, and use it as reference solution b; accurately measure 50 μL of reference solution b, place it in a 2 mL injection vial, add 950 μL of methanol, shake it well, and use it as reference solution c. Accurately measure 100 μL of reference solution c, place it in a 2 mL injection vial, add 900 μL of methanol, shake it well, and use it as reference solution; accurately measure 1.0 μL of reference solution, inject it into the gas chromatograph-mass spectrometer, and record the chromatogram.
[0042] Take 1.0g of Captopril, weigh accurately, place in a 10mL volumetric flask, dissolve with methanol and make up to the mark, shake well, filter through a microporous membrane, and take the filtrate as the test solution; perform a blank test at the same time. Accurately measure 1.0μL of the test solution and blank test solution, inject into the gas chromatograph-mass spectrometer, and record the chromatogram.
[0043] Conclusion: The retention time of D-3-acetylmercapto-2-methylpropionyl chloride in the reference solution is 5.16min, and no interfering peak appears in the blank solvent at this time. D-3-acetylmercapto-2-methylpropionyl chloride is not detected in the test solution, and there is no interfering peak. This method has good specificity.
[0044] 3. Instrument precision: Take the reference solution (quantitation limit concentration is 0.266 μg / mL), repeat the injection 6 times, and calculate the RSD of the quantitative ion peak area.
[0045] Table 2 Precision test of D-3-acetylmercapto-2-methylpropionyl chloride
[0046]
[0047] The results showed that the analytical method of D-3-acetylmercapto-2-methylpropionyl chloride had good precision.
[0048] 4. Linearity and range: Take 25.45 mg of D-3-acetylmercapto-2-methylpropanoyl chloride, accurately weigh it, place it in a 25 mL volumetric flask, dissolve it in methanol and make up to the scale, shake well, and use it as reference solution a; accurately measure 50 μL of reference solution a, place it in a 2 mL injection vial, add 950 μL of methanol, shake well, and use it as reference solution b; accurately measure 50 μL of reference solution b, place it in a 2 mL injection vial, add 950 μL of methanol, shake well, and use it as reference solution c.
[0049] Accurately measure 100μL, 130μL, 150μL, 200μL, and 250μL of reference solution c, respectively, and place them in 2mL injection vials, and add 900μL, 870μL, 850μL, 800μL, and 750μL of methanol, respectively, and shake well. According to the above chromatographic / mass spectrometric conditions, accurately measure 1.0μL of each of the above solutions and inject them into the gas chromatograph-mass spectrometer. Record the chromatogram, determine the peak area, draw the standard curve with the linear concentration as the horizontal axis and the quantitative ion peak area as the vertical axis, and calculate the regression equation. The results are shown in Table 3.
[0050] Table 3 D-3-acetylmercapto-2-methylpropanoyl chloride linear relationship determination results
[0051] Concentration (x, μg / mL) Quantitative ion peak area (y) 0.2530 213 0.3289 268 0.3795 303 0.5060 395 0.6325 502
[0052] The results showed that D-3-acetylmercapto-2-methylpropionyl chloride had a good linear relationship in the range of 0.2530-0.6325 g / mL. Regression equation: Y=757.03X+18.261, correlation coefficient: R2=0.9984.
[0053] 5. Accuracy
[0054] 1) Limit concentration accuracy (recovery rate) test:
[0055] Take 25.45 mg of D-3-acetylmercapto-2-methylpropionyl chloride, accurately weigh it, place it in a 25 mL volumetric flask, dissolve it with methanol and make up to the mark, shake it well, and use it as reference solution a; accurately measure 50 μL of reference solution a, place it in a 2 mL injection vial, add 950 μL of methanol, shake it well, and use it as reference solution b; accurately measure 50 μL of reference solution b, place it in a 2 mL injection vial, add 950 μL of methanol, shake it well, and use it as reference solution c. Accurately measure 130 μL of reference solution c, place it in a 2 mL injection vial, add 870 μL of methanol, shake it well, and use it as reference solution.
[0056] Take 1.0g of captopril, accurately weigh it, put it in a 10mL volumetric flask, and prepare 7 portions; dissolve 1 portion in methanol and make up to the scale, shake well, pass through a microporous filter, and take the filtrate as the test solution; for the other 6 portions, accurately add 130μL of the reference solution c, dissolve it in methanol and make up to the scale, shake well, pass through a microporous filter, and take the filtrate as the 100% recovery solution, and do a blank test at the same time.
[0057] Accurately measure 1.0 μL of each of the above-mentioned reference solution, blank solution, test solution, and 100% recovery solution, inject them into gas chromatography-mass spectrometry, and calculate the D-3-acetylmercapto-2-methylpropanoyl chloride content, recovery rate, and RSD results according to the external standard method.
[0058] The results are shown in Table 4.
[0059] 2) Quantitative limit concentration accuracy (recovery rate) test:
[0060] Take 23.39 mg of D-3-acetylmercapto-2-methylpropanoyl chloride, accurately weigh it, put it in a 25 mL volumetric flask, dissolve it with methanol and make up to the mark, shake it well, and use it as reference solution a; accurately measure 50 μL of reference solution a, put it in a 2 mL injection vial, add 950 μL of methanol, shake it well, and use it as reference solution b; accurately measure 50 μL of reference solution b, put it in a 2 mL injection vial, add 950 μL of methanol, shake it well, and use it as reference solution c;
[0061] Accurately measure 130 μL of reference solution c, place in a 2 mL injection vial, add 870 μL of methanol, shake well, and use as the reference solution.
[0062] Take 1.0g of captopril, accurately weigh it, put it in a 10mL volumetric flask, and prepare 4 portions; dissolve 1 portion in methanol and make up to the scale, shake well, pass through a microporous filter, and take the filtrate as the test solution; accurately add 100μL of the reference solution c to the other 3 portions, dissolve in methanol and make up to the scale, shake well, pass through a microporous filter, and take the filtrate as the quantitative limit recovery solution, and perform a blank test at the same time.
[0063] Accurately measure 1.0 μL of the reference solution, blank solution, test solution, and quantitative limit recovery solution, and inject them into the gas chromatography-mass spectrometer to calculate the content, recovery rate, and RSD of D-3-acetylmercapto-2-methylpropionyl chloride by the external standard method. The results are shown in Table 4.
[0064] Table 4 Accuracy (recovery rate) test of D-3-acetylmercapto-2-methylpropanoyl chloride
[0065]
[0066] The results showed that the analytical method for D-3-acetylmercapto-2-methylpropionyl chloride had good accuracy.
[0067] 6. Repeatability
[0068] (Preparation method is the same as the limit concentration accuracy (recovery rate) test under the accuracy item)
[0069] Take 25.45 mg of D-3-acetylmercapto-2-methylpropionyl chloride, accurately weigh it, place it in a 25 mL volumetric flask, dissolve it with methanol and make up to the mark, shake it well, and use it as reference solution a; accurately measure 50 μL of reference solution a, place it in a 2 mL injection vial, add 950 μL of methanol, shake it well, and use it as reference solution b; accurately measure 50 μL of reference solution b, place it in a 2 mL injection vial, add 950 μL of methanol, shake it well, and use it as reference solution c. Accurately measure 130 μL of reference solution c, place it in a 2 mL injection vial, add 870 μL of methanol, shake it well, and use it as reference solution.
[0070] Take 1.0g of captopril, accurately weigh it, put it in a 10mL volumetric flask, and prepare 7 portions; dissolve 1 portion in methanol and make up to the scale, shake well, pass through a microporous filter, and take the filtrate as the test solution; for the other 6 portions, accurately add 130μL of the reference solution c, dissolve it in methanol and make up to the scale, shake well, pass through a microporous filter, and take the filtrate as the 100% recovery solution, and do a blank test at the same time.
[0071] Accurately measure 1.0 μL of the reference solution, blank solution, test solution, and 100% recovery solution, inject them into the gas chromatography-mass spectrometer, and calculate the content, recovery rate, and RSD of D-3-acetylmercapto-2-methylpropanoyl chloride by the external standard method. The results are shown in Table 5.
[0072] Table 5 Repeatability test of D-3-acetylmercapto-2-methylpropanoyl chloride
[0073]
[0074] The results showed that the analytical method for D-3-acetylmercapto-2-methylpropionyl chloride had good repeatability.
[0075] 7. Intermediate precision test
[0076] Take 23.39 mg of D-3-acetylmercapto-2-methylpropionyl chloride, weigh it accurately, place it in a 25 mL volumetric flask, dissolve it with methanol and make it up to the mark, shake it well, and use it as reference solution a; accurately measure 50 μL of reference solution a, place it in a 2 mL injection vial, add 950 μL of methanol, shake it well, and use it as reference solution b; accurately measure 50 μL of reference solution b, place it in a 2 mL injection vial, add 950 μL of methanol, shake it well, and use it as reference solution c. Accurately measure 130 μL of reference solution c, place it in a 2 mL injection vial, add 870 μL of methanol, shake it well, and use it as reference solution.
[0077] Take 1.0g of captopril, accurately weigh it, put it in a 10mL volumetric flask, and prepare 7 portions; dissolve 1 portion in methanol and make up to the scale, shake well, pass through a microporous filter, and take the filtrate as the test solution; for the other 6 portions, accurately add 130μL of the reference solution c, dissolve it in methanol and make up to the scale, shake well, pass through a microporous filter, and take the filtrate as the 100% recovery solution, and do a blank test at the same time.
[0078] Accurately measure 1.0 μL of the reference solution, blank solution, test solution, and 100% recovery solution, inject them into the gas chromatography-mass spectrometer, and determine the content of different personnel and different dates according to the D-3-acetylmercapto-2-methylpropionyl chloride analysis method, and calculate the RSD. The results are shown in Table 6.
[0079] Table 6 Intermediate precision test of D-3-acetylmercapto-2-methylpropionyl chloride
[0080]
[0081] The results showed that the intermediate precision of the analytical method for D-3-acetylmercapto-2-methylpropionyl chloride was good.
[0082] 8. Solution stability test
[0083] Take 23.39 mg of D-3-acetylmercapto-2-methylpropanoyl chloride, accurately weigh it, put it in a 25 mL volumetric flask, dissolve it in methanol and make up to the scale, shake it well, and use it as reference solution a; accurately measure 50 μL of reference solution a, put it in a 2 mL injection vial, add 950 μL of methanol, shake it well, and use it as reference solution b; accurately measure 50 μL of reference solution b, put it in a 2 mL injection vial, add 950 μL of methanol, shake it well, and use it as reference solution c.
[0084] Take about 1.0 g of captopril, accurately weigh it, put it in a 10 mL volumetric flask, accurately add 130 μL of reference solution c, dissolve it with methanol and make up to the scale, shake well, pass it through a microporous filter membrane, and take the filtrate as the test solution (100% recovery solution).
[0085] Accurately measure 1.0 μL of the test solution, inject it into the gas chromatography-mass spectrometer, and record the chromatogram. Inject samples continuously for 24 hours and calculate the RSD of the quantitative ion peak area. The results are shown in Table 7.
[0086] Table 7 Solution stability test
[0087]
[0088] The results showed that D-3-acetylmercapto-2-methylpropionyl chloride in the captopril test solution had good stability within 8 hours.
[0089] 9. Durability test
[0090] Take 24.76 mg of D-3-acetylmercapto-2-methylpropionyl chloride, accurately weigh it, place it in a 25 mL volumetric flask, dissolve it with methanol and make up to the mark, shake it well, and use it as reference solution a; accurately measure 50 μL of reference solution a, place it in a 2 mL injection vial, add 950 μL of methanol, shake it well, and use it as reference solution b; accurately measure 50 μL of reference solution b, place it in a 2 mL injection vial, add 950 μL of methanol, shake it well, and use it as reference solution c. Accurately measure 130 μL of reference solution c, place it in a 2 mL injection vial, add 870 μL of methanol, shake it well, and use it as reference solution.
[0091] Take 1.0g of captopril, accurately weigh it, put it in a 10mL volumetric flask, and prepare 3 portions; dissolve 1 portion in methanol and make up to the scale, shake well, pass through a microporous filter, and take the filtrate as the test solution; for the other 2 portions, accurately add 130μL of reference solution c, dissolve in methanol and make up to the scale, shake well, pass through a microporous filter, and take the filtrate as the 100% recovery solution, and do a blank test at the same time.
[0092] By changing the injection port temperature (210°C, 220°C, 230°C), column flow rate (1.4mL / min, 1.5mL / min, 1.6mL / min) and initial column temperature (65°C, 70°C, 75°C), the above solutions were analyzed by D-3-acetylmercapto-2-methylpropanoyl chloride method to determine their contents. The results are shown in Table 8.
[0093] Table 8 D-3-acetylmercapto-2-methylpropanoyl chloride durability test
[0094]
[0095] The results showed that the analytical method for D-3-acetylmercapto-2-methylpropionyl chloride had good durability.
[0096] 3. Sample Testing
[0097] According to the above-mentioned analytical method of D-3-acetylmercapto-2-methylpropanoyl chloride, 9 batches of captopril samples were measured. The results are shown in Table 9.
[0098] Table 9 Determination results of D-3-acetylmercapto-2-methylpropanoyl chloride in 9 batches of samples
[0099]
[0100]
[0101] The results showed that 9 batches of captopril samples were tested using the D-3-acetylmercapto-2-methylpropionyl chloride analytical method, and the results were not detected, which was in compliance with the regulations.
[0102] The above description is only a preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.
Claims
1. A method for detecting the genotoxic impurity D-3-acetylmercapto-2-methylpropionyl chloride in Captopril API, characterized in that: The detection method used is gas chromatography-mass spectrometry, which comprises the following steps: (1) Preparation of test solution: accurately weigh the captopril sample, dissolve it in an alcohol solvent and make up to volume, shake well to make a 0.05-0.20 g / mL solution, filter through a microporous membrane, take the filtrate as the test solution, and prepare a blank solution at the same time; (2) Preparation of reference solution: accurately weigh D-3-acetylmercapto-2-methylpropionyl chloride reference substance, place it in a 25 mL volumetric flask, dissolve it with solvent and make up to the mark, shake well, and use it as reference solution a; accurately measure 50 μL of reference solution a, place it in a 2 mL injection vial, add 950 μL of alcohol solvent, shake well, and use it as reference solution b; accurately measure 50 μL of reference solution b, place it in a 2 mL injection vial, add 950 μL of alcohol solvent, shake well, and use it as reference solution c; accurately measure 100 μL of reference solution c, place it in a 2 mL injection vial, add 900 μL of alcohol solvent, shake well, and use it as reference solution; (3) Accurately measure 1.0 μL of each of the blank solution, reference solution, and test solution, inject them into the gas chromatography-mass spectrometer for testing, and record the chromatogram; the gas chromatography-mass spectrometry detection method conditions are as follows: Gas chromatography conditions: chromatographic column is HP-5, 30m×0.25mm×0.25μm, UI; stationary phase is 5% phenyl-95% dimethylpolysiloxane, carrier gas is helium; injection port temperature is 200-240°C; MS detector; flow rate is 1.4-1.6mL / min; split ratio is 10:1; injection volume is 1.0μL; initial column temperature is 60-75°C, maintained for 1min, then heated to 180°C at a rate of 20°C / min, then heated to 260°C at a rate of 40°C / min, and maintained at 260°C for 10min; Mass spectrometry conditions: ion source (EI) voltage, ionization energy: 70 eV, ion source temperature: 230 °C, quadrupole temperature: 150 °C, transfer line temperature: 280 °C, scanning mode: selected ion scanning, quantitative ions: 144, qualitative ions: 144, 134, 116, 101.
2. The method for detecting genotoxic impurity D-3-acetylmercapto-2-methylpropionyl chloride in Captopril API according to claim 1, characterized in that: The concentration of the test solution described in step (1) of claim 1 is 0.10 g / mL.
3. The method for detecting genotoxic impurity D-3-acetylmercapto-2-methylpropionyl chloride in Captopril API according to claim 1, characterized in that: The concentration of the reference solution in step (2) of claim 1 is 0.20 to 0.65 μg / mL.
4. The method for detecting genotoxic impurity D-3-acetylmercapto-2-methylpropionyl chloride in Captopril API according to claim 1, characterized in that: The dilution solvent in steps (1) and (2) of claim 1 is an alcohol solvent such as methanol, ethanol and isopropanol.
